Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts.

Conclusion: Improvement in survival and reduction in complications were substantial after allogeneic transplant. Relapse of cancer remains the largest obstacle to better survival outcomes.
Primary Funding Source: National Institutes of Health.
PMID: 31958813 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - January 20, 2020 Category: Internal Medicine Authors: McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, Hingorani S, Boeckh M, Flowers MD, Lee SJ, Appelbaum FR, Storb R, Martin PJ, Deeg HJ, Schoch G, Gooley TA Tags: Ann Intern Med Source Type: research